Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Antiplatelet agents in the pipeline at Boehringer Ingelheim

July 28, 1998

Wakunaga researchers patent new antiplatelet agents

July 17, 1998

New antiischemic agent put on the developmental track at Otsuka

July 17, 1998

Clopidogrel approved throughout European Union

July 16, 1998

Advisory committee recommends approval of Pletal

July 14, 1998

New thrombin inhibitors synthesized at Merck & Co.

July 13, 1998

Absence of cardiodepressive effects with beraprost

July 13, 1998

Cor Therapeutics patents novel factor Xa inhibitors

July 9, 1998

Abciximab treatment validated for prevention of ischemic complications after coronary intervention

July 9, 1998

Cor Therapeutics describes selective factor Xa inhibitors

July 8, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...